Dioscorea bulbifera: Phytotherapeutic Potential and Toxicological Risks, A Critical Review
Planta Medica · 01.07.2026 · 92 (08) · 760-773
DOI: 10.1055/a-2779-6570 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Planta Medica, erschienen am 01.07.2026. Verfasst von Emi Mathew und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, Mahatma Gandhi University, Kottayam, Kerala, India. Hauptthemen laut MEDLINE: Dioscorea, Plant Extracts, Phytotherapy. Die Arbeit nennt 121 Literaturangaben.
Abstract (Originalsprache)
Dioscorea bulbifera (air potato), a climbing perennial of the Dioscoreaceae family, is widely distributed in tropical regions and valued in Ayurveda, Traditional Chinese Medicine, and African ethnomedicine for managing inflammatory, infectious, metabolic, and neoplastic disorders. This systematic review critically evaluates its phytochemistry, pharmacology, and toxicology. Primary metabolites contribute to its nutritional value, whereas secondary metabolites–predominantly steroidal saponins, flavonoids, and diterpenoids from bulbils and tubers–underlie its wide range of reported bioactivities. African accessions are rich in clerodane diterpenoids, while Asian ones are rich in saponins and flavonoids, underscoring the need for comparative metabolomic and chemotaxonomic studies. Preclinical studies confirm antiproliferative, antioxidant, anti-inflammatory, antimicrobial, antidiabetic, and neuroprotective effects. However, furanoid diterpenoids, particularly diosbulbin B and 8-epidiosbulbin E acetate, have been shown to induce hepatotoxicity, with additional risks of nephrotoxicity, cardiotoxicity, gastrointestinal irritation, and thyroid dysfunction. Traditional processing methods, such as boiling and roasting, as well as co-administration with protective herbs, mitigate toxicity. Despite promising activity, clinical translation remains hindered by phytochemical variability, non-standardised preparations, and the complete absence of human trials. Future research should therefore focus on developing detoxified, standardised extracts supported by pharmacokinetic studies and well-designed randomised controlled trials to establish D. bulbifera as a safe and effective phytotherapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biosciences, Mahatma Gandhi University, Kottayam, Kerala, India.
- Bishop Chulaparambil Memorial College, Kottayam, Kerala, India.
- St. Berchmans College, Changanassery, Kottayam, Kerala, India.
ORCID-Profile: Emi Mathew, Philip Litto Thomas, Linu Mathew
Zitieren
APA
Mathew, E., Thomas, P. L., & Mathew, L. (2026). Dioscorea bulbifera: Phytotherapeutic Potential and Toxicological Risks, A Critical Review. Planta Medica, 92(08), 760-773. https://doi.org/10.1055/a-2779-6570
Vancouver
Mathew E, Thomas PL, Mathew L. Dioscorea bulbifera: Phytotherapeutic Potential and Toxicological Risks, A Critical Review. Planta Medica. 2026;92(08):760-773. doi:10.1055/a-2779-6570
BibTeX
@article{Mathew2026,
author = {Mathew, Emi and Thomas, Philip Litto and Mathew, Linu},
title = {Dioscorea bulbifera: Phytotherapeutic Potential and Toxicological Risks, A Critical Review},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {08},
pages = {760--773},
doi = {10.1055/a-2779-6570}
}
EUVIMED